INBX Inhibrx Biosciences, Inc.
$97.93
Inhibrx Biosciences, Inc. (INBX) Earnings News
Earnings press releases, previews and reviews for Inhibrx Biosciences, Inc. (INBX), newest first.
Friday
September 4, 2026
4:00 PM ET
Inhibrx To Host Webcast Presentation to Provide Primary Endpoint Results for INBRX-106 Phase 2 First-Line HNSCC Study
Thursday
August 13, 2026
4:04 PM ET
Inhibrx Reports Second Quarter 2026 Financial Results
Thursday
May 14, 2026
4:02 PM ET
Inhibrx Reports First Quarter 2026 Financial Results
Friday
May 8, 2026
4:00 PM ET
Inhibrx To Host Webcast Presentation to Provide Clinical Update on INBRX-106 HexAgon Study in First Line HNSCC